Cephalexin
Product Images NDC 53002-2181

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 53002-2181). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Cephalexin, depicting its molecular arrangement including a β-lactam ring, a thiazolidine ring, a phenyl group, and associated functional groups, along with a water molecule indicating the hydrate form.*

FDA Label Image

Label Image (Lbl530022181)

Label for Cephalexin 500mg capsules by RPK Pharmaceuticals, Inc., showing the product name, strength, and dosage form. The label instructs to take 1 capsule times a day for days as directed. The package contains 30 capsules and includes space for patient name, directions, prescriber, and clinic name.*

FDA Label Image

Label Image (Lbl530022540)

Cephalexin 250 mg/5 mL oral suspension label on a 200 mL bottle by RPK Pharmaceuticals, Inc. The label instructs to take 1 teaspoonful 4 times a day or as directed. It includes dosing information, storage instructions, patient name and clinic name placeholders, lot and expiration dates, and barcode details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.